IQVIA Holdings Inc
(BSP:I1QV34)
R$
300.4
0 (0%)
Market Cap: 218.09 Bil
Enterprise Value: 291.51 Bil
PE Ratio: 26.68
PB Ratio: 5.30
GF Score: 90/100 IQVIA Holdings Inc at Credit Suisse Healthcare Conference Transcript
Nov 08, 2022 / 05:10PM GMT
Release Date Price:
R$268.65
Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
All right. With that, we'll kick things off. Thank you, everybody, for joining us. Next session is IQVIA. We're happy to have with us Ron Bruehlman, CFO. I'm Dan Leonard. I cover life science tools and services for Credit Suisse. And we'll kick things straight off. Ron, welcome.
Ronald E. Bruehlman
IQVIA Holdings Inc. - Executive VP & CFO
Thank you.
Questions & Answers
Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
So you just closed up your Q3 -- reported Q3 earnings. Figured a good way to start off would be to remind us of the key highlights and takeaways from the Q3 report.
Ronald E. Bruehlman
IQVIA Holdings Inc. - Executive VP & CFO
Sure. Well, look, I think the #1 highlight, Dan, is that the market remains very strong for us. I know there's been concern, particularly about the emerging
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot